Literature DB >> 21544062

Validation of the Oxford classification of IgA nephropathy.

Andrew M Herzenberg1, Agnes B Fogo, Heather N Reich, Stéphan Troyanov, Nuket Bavbek, Alfonso E Massat, Tracy E Hunley, Michelle A Hladunewich, Bruce A Julian, Fernando C Fervenza, Daniel C Cattran.   

Abstract

The Oxford classification of IgA nephropathy (IgAN) identified four pathological elements that were of prognostic value and additive to known clinical and laboratory variables in predicting patient outcome. These features are segmental glomerulosclerosis/adhesion, mesangial hypercellularity, endocapillary proliferation, and tubular atrophy/interstitial fibrosis. Here, we tested the Oxford results using an independent cohort of 187 adults and children with IgAN from 4 centers in North America by comparing the performance of the logistic regression model and the predictive value of each of the four lesions in both data sets. The cohorts had similar clinical and histological findings, presentations, and clinicopathological correlations. During follow-up, however, the North American cohort received more immunosuppressive and antihypertensive therapies. Identifying patients with a rapid decline in the rate of renal function using the logistic model from the original study in the validation data set was good (c-statistic 0.75), although less precise than in the original study (0.82). Individually, each pathological variable offered the same predictive value in both cohorts except mesangial hypercellularity, which was a weaker predictor. Thus, this North American cohort validated the Oxford IgAN classification and supports its utilization. Further studies are needed to determine the relationship to the impact of treatment and to define the value of the mesangial hypercellularity score.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544062     DOI: 10.1038/ki.2011.126

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  70 in total

1.  Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression.

Authors:  Aron Chakera; Clare MacEwen; Shubha S Bellur; La-Or Chompuk; Daniel Lunn; Ian S D Roberts
Journal:  J Nephrol       Date:  2015-08-30       Impact factor: 3.902

Review 2.  IgA Nephropathy.

Authors:  Jennifer C Rodrigues; Mark Haas; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-03       Impact factor: 8.237

3.  Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.

Authors:  Shigeru Tanaka; Toshiharu Ninomiya; Ritsuko Katafuchi; Kosuke Masutani; Akihiro Tsuchimoto; Hideko Noguchi; Hideki Hirakata; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

Review 4.  Pathology of IgA nephropathy.

Authors:  Ian S D Roberts
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

5.  The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients.

Authors:  Ahmad Baseer Kaihan; Yoshinari Yasuda; Takayuki Katsuno; Sawako Kato; Takahiro Imaizumi; Takaya Ozeki; Manabu Hishida; Takanobu Nagata; Masahiko Ando; Naotake Tsuboi; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2017-03-27       Impact factor: 2.801

6.  Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.

Authors:  Xia-Hong Shen; Shao-Shan Liang; Hui-Mei Chen; Wei-Bo Le; Song Jiang; Cai-Hong Zeng; Min-Lin Zhou; Hai-Tao Zhang; Zhi-Hong Liu
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

7.  The new histopathologic classification of ANCA-associated GN and its association with renal outcomes in childhood.

Authors:  Damien G Noone; Marinka Twilt; Wesley N Hayes; Paul S Thorner; Susanne Benseler; Ronald M Laxer; Rulan S Parekh; Diane Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 8.237

Review 8.  New insights into the pathogenesis of IgA nephropathy.

Authors:  Jürgen Floege; Ivan C Moura; Mohamed R Daha
Journal:  Semin Immunopathol       Date:  2014-01-18       Impact factor: 9.623

Review 9.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

10.  Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.

Authors:  Heyan Wu; Xiang Fang; Zhengkun Xia; Chunlin Gao; Yingchao Peng; Xiaojie Li; Pei Zhang; Qianghuining Kuang; Ren Wang; Meiqiu Wang
Journal:  J Nephrol       Date:  2020-06-07       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.